In a recent publication from the Millman Lab titled “Genetically Engineered Brain Organoids Recapitulate Spatial and Developmental States of Glioblastoma Progression,” Dr. Matthew Ishahak and colleagues developed engineered glioblastoma brain organoids (eGBOs) to investigate tumor progression in glioblastoma (GBM), an aggressive form of brain cancer that is highly resistant to therapy. The study, published in […]
Millman Lab a 2025 Human Islet Research Network’s 10th Anniversary Meeting
In honor of World Diabetes Day, the Diabetes Research Center of the Division of Endocrinology, Metabolism and Lipid Research sponsored the 2024 Diabetes Day Symposium. The event took place on Thursday, November 7 at the Washington University School of Medicine’s Eric P. Newman Education Center, with programming aimed at bringing together scientists and trainees to […]
On May 4, Nathaniel Hogrebe, PhD; Matthew Ishahak, PhD; and Jeffrey Millman, PhD had their review titled “Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes,” published in Cell Stem Cell. In diabetes treatment, there is great potential for islet-like endocrine clusters from human pluripotent stem cells (hPSCs) to provide a limitless […]